Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[First clinical experience with extracorporeal lithotriptor EDAP LT.02].

J Bron1, K Tchala, P Sevestre

  • 1Service d'Urologie, Hôpital Saint-Louis, Paris.

Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|August 1, 1992
PubMed
Summary

This preliminary study shows the EDAP LT.02 extracorporeal lithotriptor effectively treated ureteric stones in 70 patients. Extracorporeal lithotripsy (ECL) achieved a 66% complete success rate with minimal anesthesia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Not Available].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2015
Same author

Ultraviolet laser-induced autofluorescence distinction between malignant and normal urothelial cells and tissues.

Journal of biomedical optics·2012
Same author

[Stress urinary incontinence treatment using Surgimesh® Sling, evolution on patient quality of life and sexual activity during 12 months follow-up].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2011
Same author

[Knowledge, attitude and perception about obstetric fistula by Cameroonian women].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2008
Same author

In vivo retroviral mediated gene transfer into bladder urothelium results in preferential transduction of tumoral cells.

European urology·2005
Same author

[Therapeutic strategy in urinary calculi].

Annales d'urologie·2004

Area of Science:

  • Urology
  • Medical Devices
  • Nephrology

Context:

  • Urinary stones, including kidney and ureteric stones, affect a significant patient population.
  • Current treatment modalities for urinary stones have varying success rates and potential complications.
  • The development of advanced lithotripsy devices is crucial for improving patient outcomes.

Purpose:

  • To evaluate the efficacy and safety of the EDAP LT.02 extracorporeal lithotriptor for treating ureteric stones.
  • To assess the performance of the device's double isocentric detection system (ultrasonographic and radiological) in facilitating in situ treatment.
  • To determine the success rates of extracorporeal lithotripsy (ECL) in a cohort of patients with varied stone locations.

Summary:

  • A preliminary study involved 70 patients with 89 urinary stones treated using the EDAP LT.02 extracorporeal lithotriptor.

Related Experiment Videos

  • The device features a double isocentric detection system for precise stone localization and treatment.
  • Primary extracorporeal lithotripsy (ECL) was performed without patient selection, with 69% of stones in the kidney and 22.5% in the ureter. An average of 1.2 sessions were needed, with anesthesia required in only 2 cases.
  • The study reported a 66% complete success rate, 17% partial success, and 17% failure.

    • Impact:

    • The EDAP LT.02 demonstrates promising results as a minimally invasive option for urinary stone management.
    • The device's integrated detection system may enhance treatment precision and reduce the need for anesthesia.
    • Further research with larger cohorts is warranted to confirm these findings and establish the device's role in clinical practice.